GB0424833D0 - Method - Google Patents

Method

Info

Publication number
GB0424833D0
GB0424833D0 GB0424833A GB0424833A GB0424833D0 GB 0424833 D0 GB0424833 D0 GB 0424833D0 GB 0424833 A GB0424833 A GB 0424833A GB 0424833 A GB0424833 A GB 0424833A GB 0424833 D0 GB0424833 D0 GB 0424833D0
Authority
GB
United Kingdom
Prior art keywords
photosensitiser
acne
ala
medicament
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0424833A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Photocure ASA
Original Assignee
Photocure ASA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Photocure ASA filed Critical Photocure ASA
Priority to GB0424833A priority Critical patent/GB0424833D0/en
Publication of GB0424833D0 publication Critical patent/GB0424833D0/en
Priority to CA2586195A priority patent/CA2586195C/en
Priority to DK05800149.6T priority patent/DK1814534T3/da
Priority to RU2007115601/15A priority patent/RU2385718C2/ru
Priority to PCT/GB2005/004253 priority patent/WO2006051269A1/en
Priority to US11/667,504 priority patent/US20080188558A1/en
Priority to AU2005303565A priority patent/AU2005303565B2/en
Priority to ES05800149T priority patent/ES2344986T3/es
Priority to EP05800149A priority patent/EP1814534B1/en
Priority to AT05800149T priority patent/ATE469674T1/de
Priority to CN2005800384462A priority patent/CN101056626B/zh
Priority to SI200531079T priority patent/SI1814534T1/sl
Priority to DE602005021677T priority patent/DE602005021677D1/de
Priority to JP2007540703A priority patent/JP5134370B2/ja
Priority to PT05800149T priority patent/PT1814534E/pt
Priority to PL05800149T priority patent/PL1814534T3/pl
Priority to US13/673,704 priority patent/US8546447B2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/0616—Skin treatment other than tanning
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0061—5-aminolevulinic acid-based PDT: 5-ALA-PDT involving porphyrins or precursors of protoporphyrins generated in vivo from 5-ALA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Radiology & Medical Imaging (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Semiconductor Lasers (AREA)
GB0424833A 2004-11-10 2004-11-10 Method Ceased GB0424833D0 (en)

Priority Applications (17)

Application Number Priority Date Filing Date Title
GB0424833A GB0424833D0 (en) 2004-11-10 2004-11-10 Method
PL05800149T PL1814534T3 (pl) 2004-11-10 2005-11-04 Pochodne kwasu 5-aminolewulinowego do leczenia trądziku
EP05800149A EP1814534B1 (en) 2004-11-10 2005-11-04 Derivatives of 5-aminolevulinic acid for the treatment of acne
CN2005800384462A CN101056626B (zh) 2004-11-10 2005-11-04 利用5-氨基乙酰丙酸衍生物治疗痤疮
RU2007115601/15A RU2385718C2 (ru) 2004-11-10 2005-11-04 Лечение угрей с использованием производных 5-аминолевулиновой кислоты
PCT/GB2005/004253 WO2006051269A1 (en) 2004-11-10 2005-11-04 Treatment of acne using derivatives of 5-aminolevulinic acid
US11/667,504 US20080188558A1 (en) 2004-11-10 2005-11-04 Treatment of Acne Using Derivatives of 5-Aminolevulinic Acid
AU2005303565A AU2005303565B2 (en) 2004-11-10 2005-11-04 Treatment of acne using derivatives of 5-aminolevulinic acid
ES05800149T ES2344986T3 (es) 2004-11-10 2005-11-04 Derivados del acido 5-aminolevulinico para el tratamiento del acne.
CA2586195A CA2586195C (en) 2004-11-10 2005-11-04 Treatment of acne using derivatives of 5-aminolevulinic acid
AT05800149T ATE469674T1 (de) 2004-11-10 2005-11-04 5-aminolävulinsäure-derivate zur behandlung von akne
DK05800149.6T DK1814534T3 (da) 2004-11-10 2005-11-04 Derivater af 5-aminolevulinsyre til behandling af acne
SI200531079T SI1814534T1 (sl) 2004-11-10 2005-11-04 Derivati aminolevulinske kisline za zdravljenjeaken
DE602005021677T DE602005021677D1 (de) 2004-11-10 2005-11-04 5-aminolävulinsäure-derivate zur behandlung von akne
JP2007540703A JP5134370B2 (ja) 2004-11-10 2005-11-04 ５―アミノレブリン酸の誘導体を用いる座瘡の治療方法
PT05800149T PT1814534E (pt) 2004-11-10 2005-11-04 Derivados do ácido 5-aminolevulínico para o tratamento do acne
US13/673,704 US8546447B2 (en) 2004-11-10 2012-11-09 Treatment of acne using derivatives of 5-aminolevulinic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0424833A GB0424833D0 (en) 2004-11-10 2004-11-10 Method

Publications (1)

Publication Number Publication Date
GB0424833D0 true GB0424833D0 (en) 2004-12-15

Family

ID=33523497

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0424833A Ceased GB0424833D0 (en) 2004-11-10 2004-11-10 Method

Country Status (16)

Country Link
US (2) US20080188558A1 (enExample)
EP (1) EP1814534B1 (enExample)
JP (1) JP5134370B2 (enExample)
CN (1) CN101056626B (enExample)
AT (1) ATE469674T1 (enExample)
AU (1) AU2005303565B2 (enExample)
CA (1) CA2586195C (enExample)
DE (1) DE602005021677D1 (enExample)
DK (1) DK1814534T3 (enExample)
ES (1) ES2344986T3 (enExample)
GB (1) GB0424833D0 (enExample)
PL (1) PL1814534T3 (enExample)
PT (1) PT1814534E (enExample)
RU (1) RU2385718C2 (enExample)
SI (1) SI1814534T1 (enExample)
WO (1) WO2006051269A1 (enExample)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0525504D0 (en) 2005-12-14 2006-01-25 Bristol Myers Squibb Co Antimicrobial composition
US20110224598A1 (en) * 2010-03-12 2011-09-15 Daniel Barolet Radiant near infrared light emitting diode exposure as skin preparation
GB0609809D0 (en) * 2006-05-17 2006-06-28 Photocure Asa Product
KR100796450B1 (ko) * 2006-06-29 2008-01-22 전남대학교산학협력단 5-아미노레불린산의 불포화 알킬 에스터 및 약학적으로허용되는 그의 염, 이의 제조방법 및 이의 용도
GB0700580D0 (en) * 2007-01-11 2007-02-21 Photocure Asa Use
WO2009003173A1 (en) 2007-06-27 2008-12-31 The General Hospital Corporation Method and apparatus for optical inhibition of photodymanic therapy
AU2008337067A1 (en) * 2007-12-14 2009-06-25 Photoderma Sa Novel compounds useful in therapeutic and cosmetic methods
GB0823265D0 (en) * 2008-12-20 2009-01-28 Convatec Technologies Inc Antimicrobial Composition
GB0823472D0 (en) 2008-12-23 2009-01-28 Photocure Asa Product
GB0900461D0 (en) 2009-01-12 2009-02-11 Photocure Asa Photodynamic therapy device
BRPI1010761A2 (pt) 2009-06-11 2016-03-22 Photocure Asa "composições semi-sólidas e produtos farmacêuticos"
EP2542208A1 (en) 2010-03-01 2013-01-09 Photocure ASA Cosmetic compositions
US20130211215A1 (en) 2010-06-23 2013-08-15 Photocure Asa Hyperosmotic preparations comprising 5-aminolevulinic acid or derivative as photosensitizing agent
CA2804337A1 (en) 2010-07-09 2012-01-12 Photocure Asa Dry compositions and devices containing such dry compositions for use in photodynamic therapy or photodynamic diagnosis
US9572880B2 (en) 2010-08-27 2017-02-21 Sienna Biopharmaceuticals, Inc. Ultrasound delivery of nanoparticles
DK3213738T3 (da) 2010-08-27 2020-03-30 Sebacia Inc Sammensætninger og fremgangsmåder til målrettet termomodulering
GB201020236D0 (en) 2010-11-30 2011-01-12 Convatec Technologies Inc A composition for detecting biofilms on viable tissues
CN104152530B (zh) 2010-12-24 2017-09-19 爱科来株式会社 癌细胞的检测方法
KR101308652B1 (ko) * 2011-05-19 2013-09-13 제너럴바이오(주) Ｍａｌ을 이용한 여드름 치료 조성물
US20140276107A1 (en) 2011-10-14 2014-09-18 Photocure Asa Photodynamic diagnosis
US20140316534A1 (en) 2011-10-14 2014-10-23 Photocure Asa Stent
RU2615870C2 (ru) 2011-12-19 2017-04-11 ФотоКьюэр АСА Устройство облучения
WO2013092936A2 (en) * 2011-12-20 2013-06-27 Galderma Research & Development Use of 5-aminolevulinic acid and esters, in combination with a vitamin d derivative or analog in photochemotherapy, and their uses in treating acne
IN2015DN00837A (enExample) 2012-08-03 2015-06-12 Photocure Asa
CA2881439C (en) * 2012-08-10 2017-08-29 Dusa Pharmaceuticals, Inc. Method for the treatment of acne
US20140067024A1 (en) 2012-08-30 2014-03-06 Photocure Asa Dual panel photodynamic therapy lamp
DK2906286T3 (en) 2012-10-11 2017-07-17 Nanocomposix Inc SILVER CHARACTER COMPOSITIONS AND PROCEDURES
MX2015007771A (es) 2012-12-20 2015-09-04 Convatec Technologies Inc Procesamiento de fibras celulosicas quimicamente modificadas.
KR101623553B1 (ko) * 2013-07-23 2016-05-23 동성제약주식회사 여드름 치료, 예방 또는 개선에 유효한 클로린 e6
WO2015091037A1 (en) 2013-12-20 2015-06-25 Galderma Research & Development Pulse photodynamic treatment of photodamaged skin
JP2017502090A (ja) 2014-01-10 2017-01-19 セバシア，インコーポレイテッド 皮膚科用途のエネルギー吸収物質を含む組成物の使用のための治療間隔
US9956426B2 (en) 2015-02-26 2018-05-01 Amol Punjabi Upconverting nanoparticles
US20160287615A1 (en) * 2015-04-03 2016-10-06 BioPharmX, Inc. Novel encapsulation of fluorescent, photo-sensitive, or oxygen-sensitive active ingredient for topical application
US10603508B2 (en) 2015-10-15 2020-03-31 Dusa Pharmaceuticals, Inc. Adjustable illuminators and methods for photodynamic therapy and diagnosis
ES2860807T3 (es) 2015-10-15 2021-10-05 Dusa Pharmaceuticals Inc Iluminador ajustable para terapia y diagnóstico fotodinámicos
CN106801037B (zh) * 2017-01-06 2021-01-19 中国人民解放军南京军区福州总医院 体外痤疮炎症模型的建立方法及其应用
US10632324B2 (en) 2017-04-27 2020-04-28 9127-4910 Quebec Inc. Method for the treatment of skin tissues
WO2019018408A1 (en) * 2017-07-17 2019-01-24 Andrea Willey METHOD OF PHOTODYNAMIC THERAPY AGAINST SKIN DISORDERS
US10357567B1 (en) 2018-01-12 2019-07-23 Dusa Pharmaceuticals, Inc. Methods for photodynamic therapy
KR102171200B1 (ko) * 2018-11-20 2020-10-28 제너럴바이오(주) 5-아미노레불린산 수화염화물과 그 유도체를 유효성분으로 함유하는 여드름성 피부염 개선 또는 그의 조성물
KR102265592B1 (ko) * 2020-10-29 2021-06-17 김진왕 5-아미노레불린산 수화염화물을 포함하는 조성물
KR20250021825A (ko) 2023-08-07 2025-02-14 주식회사 아스트로젠 5-아미노레불린산 유도체 및 이를 포함하는 약학 조성물

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5234940A (en) * 1989-07-28 1993-08-10 Queen's University Photochemotherapeutic method using 5-aminolevulinic acid and precursors thereof
US5955490A (en) * 1989-07-28 1999-09-21 Queen's University At Kingston Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins
US5422093A (en) * 1989-07-28 1995-06-06 Queen's University Photochemotherapeutic method using 5-aminolevulinic acid and precursors thereof
US6710066B2 (en) * 1989-07-28 2004-03-23 Queen's University At Kingston Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins
US5079262A (en) * 1989-07-28 1992-01-07 Queen's University At Kingston Method of detection and treatment of malignant and non-malignant lesions utilizing 5-aminolevulinic acid
US5713845A (en) * 1991-10-29 1998-02-03 Thermolase Corporation Laser assisted drug delivery
PL308116A1 (en) 1992-09-21 1995-07-24 Quadra Logic Technologies Percutaneous in vivo activation of a photosensitive factor present in blood
FR2714602B1 (fr) * 1993-12-30 1996-02-09 Oreal Composition antiacnéique pour le traitement simultané des couches superficielles et profondes de la peau, son utilisation.
CA2215069C (en) * 1995-03-10 2006-09-12 Photocure As Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
GB9700396D0 (en) * 1997-01-10 1997-02-26 Photocure As Photochemotherapeutic compositions
JPH1112197A (ja) 1997-06-18 1999-01-19 Cosmo Sogo Kenkyusho:Kk 悪性腫瘍診断剤及び治療剤
US6183773B1 (en) * 1999-01-04 2001-02-06 The General Hospital Corporation Targeting of sebaceous follicles as a treatment of sebaceous gland disorders
DE10003620A1 (de) 2000-01-28 2001-08-02 Asat Ag Applied Science & Tech 5-Aminolävulinsäure-Formulierung in nichtwässrigen Lösungsmitteln
GB0018528D0 (en) * 2000-07-27 2000-09-13 Photocure Asa Compounds
ATE463237T1 (de) * 2000-08-16 2010-04-15 Gen Hospital Corp Topische aminolevulinsäure-photodynamische therapie für akne vulgaris
GB0118251D0 (en) 2001-07-26 2001-09-19 Photocure Asa Method
CA2466425A1 (en) * 2001-11-09 2003-05-15 Qlt Inc. Photodynamic therapy for the treatment of hair loss
US20040048842A1 (en) * 2002-09-10 2004-03-11 Mcmillan Kathleen Method of treating skin disorders
US20050209330A1 (en) * 2004-03-22 2005-09-22 Syneron Medical Ltd. Method of treatment of skin
US20050209331A1 (en) * 2004-03-22 2005-09-22 Syneron Medical Ltd. Method of treatment of skin
GB0406917D0 (en) 2004-03-26 2004-04-28 Photocure Asa Compounds

Also Published As

Publication number Publication date
EP1814534B1 (en) 2010-06-02
JP2008519812A (ja) 2008-06-12
CN101056626A (zh) 2007-10-17
PT1814534E (pt) 2010-06-15
WO2006051269A1 (en) 2006-05-18
CN101056626B (zh) 2011-12-14
RU2007115601A (ru) 2008-12-20
JP5134370B2 (ja) 2013-01-30
EP1814534A1 (en) 2007-08-08
US20130066256A1 (en) 2013-03-14
US20080188558A1 (en) 2008-08-07
AU2005303565A1 (en) 2006-05-18
CA2586195A1 (en) 2006-05-18
AU2005303565B2 (en) 2011-04-14
RU2385718C2 (ru) 2010-04-10
DK1814534T3 (da) 2010-09-20
CA2586195C (en) 2013-12-31
ATE469674T1 (de) 2010-06-15
US8546447B2 (en) 2013-10-01
DE602005021677D1 (de) 2010-07-15
ES2344986T3 (es) 2010-09-13
PL1814534T3 (pl) 2010-11-30
SI1814534T1 (sl) 2010-09-30

Similar Documents

Publication Publication Date Title
GB0424833D0 (en) Method
IL189694A0 (en) Biphenyl derivatives and their use in treating hepatitis c
AU2003279338A1 (en) Phenethanolamine derivatives for the treatment of respiratory diseases
AU2003210428A1 (en) Phenethanolamine derivatives for treatment of respiratory diseases
IL193252A0 (en) N-hydroxyacrylamide compounds
NZ597510A (en) NOVEL ACETYLSALICYLIC ACID SALTS, the salts are 4-trimethylammoniobutanoate, L-carnitine and meldonium
TW200630086A (en) Gaba analog prodrug sustained release oral dosage forms
CY1116831T1 (el) ΧΡΗΣΗ 24-norUDCA
WO2005089872A3 (en) Treatment of local pain
WO2001056573A8 (en) Use of cox-2 inhibitors as gastroprokinetics
IL162384A0 (en) Composition inhibiting matrix-metallproteinases for the treatment of neoplastic diseases
IN2005KO00312A (enExample)
UA97348C2 (en) HETEROCYCLIC NF-kB INHIBITORS
WO2008090736A1 (ja) アルツハイマー型認知症の予防及び治療のための医薬
MX2009005247A (es) Metodos para mejorar la biodisponibilidad de un inhibidor de renina.
TW200501970A (en) Use of PVP-iodine liposomes for treatment of acne
MY145122A (en) Phenylacetic acid derivatives as cox-2 inhibitors
WO2006039414A3 (en) Treatment method
WO2006133231A3 (en) Treatment for neurodegenerative diseases
MX2009011817A (es) Formulaciones de aminoacido n-halogenado que contienen acido alifatico.
EA200800706A1 (ru) Способ приготовления кандесартана цилексетила
AU2003216965A1 (en) Compounds, particularly of urea derivatives or ester derivatives of haloacetamidobenzoic acid and use thereof for the treatment of parasitic diseases
AU2003267751A1 (en) Use of epothilone derivatives for the treatment of hyperparathyroidism
WO2008149971A1 (ja) 脳動脈瘤の治療または予防薬
WO2003094968A3 (en) Combination of a proton pump inhibitor and a respiratory agent for the treatment of respiratory diseases

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)